SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models

Eliza Żyłkiewicz; Tomasz Rzymski; Michał Mikuła; Agnieszka Dreas; Katarzyna Wiklik; Anna Wróbel; Aniela Gołas; Izabela Dolata; K. Wojcik; Magdalena Masiejczyk

doi:10.1016/s0959-8049(16)32992-6

SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models

Identifier:nobleid.org/w1/20260515/B2D2EB2A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2D2EB2A.svg?ark=w1%2F20260515%2FB2D2EB2A)](https://nobleid.org/work/w1/20260515/B2D2EB2A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models

Identifier:nobleid.org/w1/20260515/B2D2EB2A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2D2EB2A.svg?ark=w1%2F20260515%2FB2D2EB2A)](https://nobleid.org/work/w1/20260515/B2D2EB2A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work